Covariate | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
OR | 95%CI | p-value | OR | 95%CI | p-value | |
Sex, Male | 1.590 | 1.001–2.527 | 0.050 |  |  |  |
Age, ≥ 60 years | 3.257 | 1.927–5.505 |  < 0.05* | 4.031 | 2.021–8.041 |  < 0.05* |
IPI,3–5 | 5.818 | 3.561–9.506 |  < 0.05* |  |  |  |
ECOG,3–5 | 7.666 | 3.810–15.423 |  < 0.05* | 3.610 | 1.572–8.290 |  < 0.05* |
Stage,III-IV | 7.195 | 3.955–13.088 |  < 0.05* | 2.737 | 1.255–5.969 |  < 0.05* |
B symptoms | 2.389 | 1.516–3.766 |  < 0.05* |  |  |  |
Bone marrow | 5.613 | 3.077–10.237 |  < 0.05* | 2.581 | 1.173–5.683 |  < 0.05* |
Involvement Albumin, < 35 g/L | 2.993 | 1.742–5.141 |  < 0.05* |  |  |  |
EBV,Positive | 2.233 | 1.409–3.541 | 0.05 | 2.090 | 1.170–3.734 |  < 0.05* |
Extra-nodal, > 1 | 3.118 | 1.936–5.021 |  < 0.05* |  |  |  |
LY(× 109/L) < 0.8 | 3.565 | 2.042–6.224 |  < 0.05* |  |  |  |
MONO(× 109/L) > 1 | 2.610 | 0.969–7.028 | 0.058 |  |  |  |
PLT(× 109/L) < 83 | 7.847 | 2.759–22.318 |  < 0.05* |  |  |  |
Elevated LDH | 2.263 | 1.429–3.585 |  < 0.05* |  |  |  |
Elevated β2-MG | 2.672 | 1.683–4.243 |  < 0.05* |  |  |  |
LMR ≤ 1.68 | 4.955 | 2.816–8.717 |  < 0.05* | 1.996 | 0.906–4.397 | 0.086 |
PMR ≤ 300 | 4.869 | 2.767–8.567 |  < 0.05* | 1.851 | 0.873–3.924 | 0.108 |